| Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia Journal of Clinical Oncology 20 (29), 2889-96, 2011 | 484* | 2011 |
| Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further … E Taskesen, L Bullinger, A Corbacioglu, MA Sanders, CAJ Erpelinck, ... Blood, The Journal of the American Society of Hematology 117 (8), 2469-2475, 2011 | 454 | 2011 |
| Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes F Thol, I Friesen, F Damm, H Yun, EM Weissinger, J Krauter, K Wagner, ... Journal of Clinical Oncology 29 (18), 2499-2506, 2011 | 358 | 2011 |
| Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse … K Wagner, F Damm, G Göhring, K Görlich, M Heuser, I Schäfer, ... Journal of clinical oncology 28 (14), 2356-2364, 2010 | 321 | 2010 |
| Acquired initiating mutations in early hematopoietic cells of CLL patients F Damm, E Mylonas, A Cosson, K Yoshida, V Della Valle, E Mouly, ... Cancer discovery 4 (9), 1088-1101, 2014 | 311 | 2014 |
| Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes F Damm, O Kosmider, V Gelsi-Boyer, A Renneville, N Carbuccia, ... Blood, The Journal of the American Society of Hematology 119 (14), 3211-3218, 2012 | 295 | 2012 |
| IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis F Thol, EM Weissinger, J Krauter, K Wagner, F Damm, M Wichmann, ... Haematologica 95 (10), 1668, 2010 | 250 | 2010 |
| BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders F Damm, V Chesnais, Y Nagata, K Yoshida, L Scourzic, Y Okuno, ... Blood, The Journal of the American Society of Hematology 122 (18), 3169-3177, 2013 | 229 | 2013 |
| Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications F Thol, R Bollin, M Gehlhaar, C Walter, M Dugas, KJ Suchanek, ... Blood, The Journal of the American Society of Hematology 123 (6), 914-920, 2014 | 226 | 2014 |
| Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia F Thol, F Damm, K Wagner, G Göhring, B Schlegelberger, D Hoelzer, ... Blood, The Journal of the American Society of Hematology 116 (4), 614-616, 2010 | 224 | 2010 |
| Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation M Frick, W Chan, CM Arends, R Hablesreiter, A Halik, M Heuser, ... Journal of Clinical Oncology 37 (5), 375-385, 2019 | 213 | 2019 |
| Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis CM Arends, J Galan-Sousa, K Hoyer, W Chan, M Jäger, K Yoshida, ... Leukemia 32 (9), 1908-1919, 2018 | 179 | 2018 |
| Single Nucleotide Polymorphism in the Mutational Hotspot of WT1 Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia F Damm, M Heuser, M Morgan, H Yun, A Großhennig, G Göhring, ... Journal of Clinical Oncology 28 (4), 578-585, 2010 | 157 | 2010 |
| Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations F Thol, B Kölking, F Damm, K Reinhardt, JH Klusmann, D Reinhardt, ... Genes, Chromosomes and Cancer 51 (7), 689-695, 2012 | 155 | 2012 |
| Integrative prognostic risk score in acute myeloid leukemia with normal karyotype F Damm, M Heuser, M Morgan, K Wagner, K Görlich, A Großhennig, ... Blood, The Journal of the American Society of Hematology 117 (17), 4561-4568, 2011 | 134 | 2011 |
| SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias F Damm, R Itzykson, O Kosmider, N Droin, A Renneville, V Chesnais, ... Leukemia 27 (6), 1401-1403, 2013 | 131 | 2013 |
| Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter, M Heuser, ... Blood, The Journal of the American Society of Hematology 133 (10), 1140-1151, 2019 | 130 | 2019 |
| SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications F Damm, F Thol, O Kosmider, S Kade, P Löffeld, F Dreyfus, ... Leukemia 26 (5), 1137-1140, 2012 | 118 | 2012 |
| Rare occurrence of DNMT3A mutations in myelodysplastic syndromes F Thol, C Winschel, A Lüdeking, H Yun, I Friesen, F Damm, K Wagner, ... Haematologica 96 (12), 1870, 2011 | 107 | 2011 |
| Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ... Blood, The Journal of the American Society of Hematology 128 (23), 2666-2670, 2016 | 100 | 2016 |
